Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BsUFA III Expands Biosimilar Supplement Review Goals To Speed Approvals

Executive Summary

Six supplement categories based on submission content will be created with review goals between three and 10 months.

You may also be interested in...

US FDA Hiring Data: CBER Exceeds CDER In Progress Toward Goals

Through three-quarters of fiscal year 2023, CBER had hired nearly 70% of the mandated new PDUFA VII employees, while CDER had only hired 40%. The drug center also hired only 36% of the required new BsUFA III employees.

US FDA’s Marks Worries Someone May Stop Hybrid Work System

CBER Director Peter Marks said the FDA’s remote and in-person work system is functioning well and continues to help recruitment.

US FDA User Fee Staffing: The Objective Capacity Planning Adjuster Often Needs Subjective Review

The FDA has overruled the results from its own formula intended to match resource levels with workload every time except once.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts